Statistics
Publications
2
Citations
844
H-Index
2
Active since
2014
Wenjing Zhu is an author at Novartis (Switzerland) specializing in medicine, natural sciences, and optogenetics.
Publications per year
2014–2017
2
2
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke et al. · Nature · 2017 · 574 citations
1–2 of 2